A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13-52) to modulate microvascular but not thermal hyperalgesia responses

Citation
Dq. Chu et al., A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13-52) to modulate microvascular but not thermal hyperalgesia responses, BR J PHARM, 130(7), 2000, pp. 1589-1596
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
130
Issue
7
Year of publication
2000
Pages
1589 - 1596
Database
ISI
SICI code
0007-1188(200008)130:7<1589:ACSOTA>2.0.ZU;2-1
Abstract
1 Calcitonin gene-related peptide (CGRP), a neuropeptide, is a potent vasod ilator. Adrenomedullin (ADM) is suggested to be produced by vascular cells in inflamed tissue. ADM shares some structural homology with CGRP. We have compared the ability of CGRP and ADM to modulate microvascular and thermal hyperalgesic responses in rat skin. Vasodilator activity was assessed by la ser Doppler flowmetry, inflammatory oedema by the extravascular accumulatio n of intravenously-injected labelled albumin, and neutrophil accumulation b y tissue myeloperoxidase, in dorsal skin. Hyperalgesia was assessed by a th ermal hyperalgesimeter in paw skin. 2 ADM (10-300 pmol) was 3 fold less potent than CGRP (3-100 pmol) as a dire ct vasodilator. CGRP (30 pmol) potentiated oedema formation induced by medi ators of increased microvascular permeability, as expected (P<0.01). Howeve r, ADM (30-100 pmol) was without a potentiating effect, although ADM (300 p mol) was effective (P<0.01). By comparison ADM (100 pmol) potentiated neutr ophil accumulation induced by interleukin-1 beta (P<0.05), whereas CGRP (30 pmol) did not. No thermal hyperalgesia was observed to either CGRP or ADM, when given as single or repeated treatments. 3 Thus despite a dilator activity neither CGRP nor ADM appears to mediate h yperalgesic activity in the periphery. However ADM, like CGRP, has the abil ity to potentiate inflammatory oedema formation and, in addition, ADM can p otentiate neutrophil accumulation. 4 ADM may, as suggested for CGRP, act as a modulator of the vascular phases of inflammation. The property of the two compounds of evoking differential microvascular responses and neutrophil accumulation may be due to differin g mechanisms of action.